VBI reports new preclinical data on COVID-19 vaccine candidates VBI-2902, VBI-2905 and VBI-2901 Sep. 30, 2021
Targeting KIR3DS1/HLA-F axis as new therapeutic strategy against human adenovirus infections Sep. 29, 2021
Beam Therapeutics presents in vitro data on use of cytosine base editors for hepatitis B Sep. 28, 2021
Chimeric spike mRNA-LNP vaccines show cross-protection against Sarbecovirus strains in vivo Sep. 27, 2021
RSS